logo
UAE: Postpartum depression in men 'easy to miss', affects 8-10% of fathers globally

UAE: Postpartum depression in men 'easy to miss', affects 8-10% of fathers globally

Khaleej Times2 days ago
When Dubai resident MH became a father for the first time, he was expecting to feel fulfilled and happy. Instead, he began experiencing depressive symptoms which took a toll on his relationship, his job and his bond with the baby. By the time the baby was six months old, MH sought mental health help after his sense of helplessness and self-criticism had intensified.
'Therapy focused on helping him understand and manage his emotions and on finding practical, solution-focused strategies to rebuild his confidence and connection with his family,' said Dr Aida Suhaimi, Clinical Psychologist at Medcare Camali Clinic. 'Over time with consistent support, he began to feel more in control, re-engaged with his child, and reported a stronger relationship with his partner.'
According to Dr Meera T Anto, Specialist Obstetrician and Gynecologist at International Modern Hospital Dubai, paternal postpartum depression affects 8 to 10 per cent of fathers globally, with some studies reporting rates as high as 25 per cent during the 3–6 months postpartum period.
Dr Aida added that when the wife suffers PPD — as in M.H.'s case Z — the incidence goes up by 50 percent.
Unreported
However, several experts pointed out that PPD often goes unreported. 'Fathers who develop depression may experience a range of symptoms including feelings of sadness, anxiety and irritability, as well as changes in their usual eating or sleeping patterns,' said Dr Hollie Shannon, Clinical Psychologist at Sage Clinics. 'However, it can be easy to miss or disregard these warning signs in the chaos of everyday life with a newborn. Some fathers may actively mask the fact that they are struggling to cope as they worry about being perceived as a failure or burden to their family.'
Dr Meera supported her observations. 'Paternal PPD is typically diagnosed using tools like the Edinburgh Postnatal Depression Scale, adapted for men, or general depression inventories,' she said. 'However, fathers are less likely to be screened, and many healthcare settings focus primarily on mothers. Fathers are often present only at the birth and pediatric checkups, where they are rarely screened. There is no standardized guideline in most countries to routinely screen fathers for PPD.'
Dr Aida added that the depression comes from a combination of 'life stressors, transformations and diminishing identity' among other factors. 'This comes from a combination of factors and the acknowledgment that your brain can change as you become a parent,' she said. 'In most of the cases, just like PPD in mothers, but more so in fathers, the condition goes unrecognised or untreated.'
Seek help
Dr Meera said it was important for men to speak to doctors and seek help. 'They should ask about mental health screening or referrals and access support through clinics with men's mental health services or family therapy,' she said. 'There are also UAE-based online platforms like Takalam or Mindforce DXB that offer virtual mental health support."
She added that men must learn to break the stigma and overcome the cultural expectations that 'often silence men' to take charge of their mental health.
Dr Aida said that new fathers can deal with the emotional and practical challenges of having a baby by being involved in parenting, strengthening the infant-baby bond, socialising with the other new fathers in their peers and seeking professional help when required and taking care of themselves.
Dr Hollie added that just like new mothers, new fathers also need emotional support. 'We need to hear that we are doing a good job every day, but especially on the difficult days. So couples need to make the time to talk and really listen to one another so they can feel more connected and supported on their parenting journey,' she said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Study finds long-term health benefits from bariatric surgery and liver transplant
Study finds long-term health benefits from bariatric surgery and liver transplant

Zawya

time6 minutes ago

  • Zawya

Study finds long-term health benefits from bariatric surgery and liver transplant

Dubai, United Arab Emirates - Simultaneous bariatric surgery and liver transplant for patients who are severely obese is safe and improves long-term health outcomes, according to a recent Mayo Clinic study. This combined approach offers a needed solution for these patients who are often denied a lifesaving liver transplant due to their weight. The 10-year study, published in the Journal of Hepatology, compared patients who received only a liver transplant with those who underwent both a liver transplant and bariatric surgery. The combined approach resulted in sustained weight loss, reduced risk of type 2 diabetes and lower risk of fatty liver disease recurrence. Importantly, the combined procedure posed no additional risks compared to liver transplant alone. "We've been amazed by the transformation our patients experience," says Julie Heimbach, M.D., director of Mayo Clinic Transplant Center in Minnesota and the study's senior author. "This dual approach prevents long-term obesity complications like diabetes, heart disease and cancer, while also preventing fatty liver disease recurrence." How obesity and liver disease are connected The percentage of liver transplant candidates in the U.S. with obesity continues to climb, with more than 41% of candidates having a body mass index above 30 in 2022. Obesity puts people at risk of developing metabolic dysfunction-associated steatotic liver disease, or MASLD, formerly known as nonalcoholic fatty liver disease. It's a condition where excess fat accumulates in the liver, which can lead to inflammation, scarring and advanced liver disease. Patients with a body mass index of 40 are more likely to be denied a transplant due to their weight. "Since MASLD is a leading cause of liver failure, it only makes sense to protect the precious, lifegiving new liver from the same damage that led to the patient needing a transplant in the first place. Safely combining the two procedures protects the transplanted liver and can provide profound health benefits to these patients," says Todd Kellogg, M.D., Mayo Clinic bariatric surgeon and the study's co-author. What about using new prescription medications for weight loss? New weight loss medications, such as GLP-1s, are being used to help some pre-transplant and post-transplant patients manage their weight. Still, Mayo Clinic experts say bariatric surgery remains an important option for patients with severe obesity due to its safety, proven effectiveness and lasting results. Another recent Mayo study related to kidney transplant patients supports this. "The patients that we're talking about really have a significant amount of extra weight. The issue with the GLP-1 medications is they are effective in terms of weight loss as well as other benefits which are being identified, but they may not get these patients with severe obesity to their lasting goal of a healthier weight," Dr. Heimbach says. Bringing together experts from different medical specialties is essential when treating these patients, says Ty Diwan, M.D., Mayo Clinic transplant surgeon and the study's co-author. "This study shows that caring for these complex patients extends beyond the transplant itself," Dr. Diwan says. "Multidisciplinary care is required to maximize patient outcomes, and that is what we see in this data. By bringing together experts in very different fields, we've improved patient care and overall health outcomes."

Burjeel reports 129% increase in Q2 net profit, revenue grows 18.7%
Burjeel reports 129% increase in Q2 net profit, revenue grows 18.7%

Zawya

time36 minutes ago

  • Zawya

Burjeel reports 129% increase in Q2 net profit, revenue grows 18.7%

UAE - Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, has delivered a strong top-line growth of 18.7% to AED1,403 million ($381.98 million) in Q2 2025, driven by a 12.1% increase in patient footfall, higher patient yield, and the continued ramp-up of newly launched facilities across the network. Revenue in H1'25 rose 12.2% to AED2,677 million, with total patient visits reaching 3.4 million, the healthcare provider said. EBITDA rose 59.4% to AED306 million in Q2 2025, fueled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. This includes AED72 million in gains from lease liability derecognition following the Dubai Medeor Hospital acquisition. The EBITDA margin expanded 5.6 p.p. to 21.8%. In H1'25, EBITDA increased 14.2% to AED487 million, with a margin of 18.2%. Net profit surged 128.9% to AED148 million ($40.29 million) in Q2' 2025, reflecting margin expansion, enhanced operating leverage, and asset optimization. In H1'25, net profit rose 10.6% to AED187 million. Specialised Services, expansion Burjeel Holdings accelerated its strategic execution in Q2 2025 with a series of high-impact initiatives that deepened specialisation and broadened patient access. The group expanded its advanced oncology network, integrating Dubai's Advanced Care Oncology Center and opening new Burjeel Cancer Institute (BCI) clinics in Al Ain, Sharjah, and Oman, reinforcing its position as a regional leader in complex cancer care. The UAE's first dedicated cancer pharmacy was also inaugurated, strengthening oncology support infrastructure. In parallel, Burjeel launched a regional mental health platform through its joint venture Alkalma, opening four specialist mental health centers across the UAE and Saudi Arabia. This marked the first phase of a multi-year expansion strategy aimed at addressing rising demand for mental wellness services. In Saudi Arabia, the Group acquired a major physiotherapy facility in Riyadh under the PhysioTherabia platform, adding scale and unlocking turnaround potential through secured government contracts. Investments in operational resilience and access continued with the AED170 million acquisition of the Medeor Hospital Dubai building, converting long-term lease obligations into ownership and enhancing cost structure flexibility. The group also expanded its primary care footprint with a new medical center launched on Saadiyat Island, aligning with its growth strategy in high-yield urban catchments. In medical innovation, Burjeel launched Docktour, a transformative healthcare logistics joint venture with AD Ports Group, aiming to redefine how medical services and infrastructure are delivered to underserved and remote communities. Several specialised centers were introduced, including the region's first Al Muderis Osseointegration Clinic for advanced limb reconstruction, a state-of-the-art Epilepsy Monitoring Unit, and expanded capabilities in rare diseases, hematology, and metabolic research. Additionally, the Group continued its digital transformation with AI-powered diagnostics and led groundbreaking research in microgravity, aiming to transform care for patients with diabetes in space and on Earth. John Sunil, Chief Executive Officer of Burjeel Holdings, said: 'The second quarter delivered exceptionally strong results, with 19% revenue growth driven by a 12% increase in patient footfall and improved yield. EBITDA rose by 59%, accompanied by a margin uplift to 22%. This robust performance significantly strengthened the first-half outcome, underscoring Burjeel Holdings' resilience and long-term sustainable growth. 'These results reflect tangible progress in key operational areas such as physician manpower optimization, formulary management, and cost control, while our strategic focus on super-specialty care is beginning to yield measurable benefits, enhancing both revenue and profitability. We continue to invest in high-value services and next-generation care facilities to support long-term momentum. 'We also advanced key strategic priorities, reinforcing leadership in complex care across oncology, transplants, fertility, mental health, and diagnostics. Our oncology platform is now the UAE's largest private network, featuring new cancer clinics and cell and gene therapy capabilities. The Alkalma mental health platform is scaling regionally, alongside rehabilitation services through over 30 PhysioTherabia centers in Saudi Arabia. Additionally, we introduced the region's first Osseointegration Clinic for cutting-edge prosthetic care. 'In parallel with expanding our network of primary care and medical centers, we deepened partnerships with government and corporate stakeholders and accelerated digital integration through Oracle Health EMR and AI-powered tools. Building on this platform, we entered into pivotal partnerships in oncology, value-based care, diagnostics, and international healthcare innovation, establishing the Group as the healthcare partner of choice. 'Burjeel Holdings is uniquely positioned to capture significant opportunities across the region, supported by rising demand for complex care and a growing population. Our focus remains on converting recent investments into sustained expansion and margin improvement, while maintaining disciplined financial management to support long-term shareholder value. Net profit growth of 129% in the reporting quarter reinforces this trajectory and strengthens the foundation for consistent shareholder returns.' Growth drivers Oncology remained a core growth driver, with revenue rising 36.7% in Q2'25 and 38.1% in H1'25, underpinned by oncology network expansion and improved conversion in surgical and advanced therapies. Other specialties also recorded solid gains in H1'25, including urology (+18%), emergency medicine (+17%), cardiology (+16%), and gastroenterology (+13%). Inpatient footfall rose 17.7% in Q2'25, reflecting strong demand across key specialties and a ramp-up in elective surgeries post-Ramadan. The group performed 22,930 surgeries, up 18.7%, with momentum concentrated at Burjeel Medical City, Burjeel Specialty Hospital Sharjah, Lifecare Hospital Musaffah and Burjeel Royal Hospital Al Ain. Bed occupancy improved to 69%, up from 65% a year ago, and averaged 69% in H1'25. Inpatient volumes rose 14.6% over the first half. Outpatient footfall grew 12.0% in Q2'25, accelerating from 5.2% in Q1, driven by primary care and physiotherapy centers, along with robust demand in oncology, pediatrics, ophthalmology, and family medicine. Utilization improved to 68%, up from 65% in Q1'25, enabled by optimized hiring and scaling of clinical teams. Leading facilities included Burjeel Medical City, Lifecare Hospital Baniyas, and Burjeel Day Surgery Center Barari. In H1'25, outpatient volumes increased 8.6%.

Saudi German Hospital's revenues surpass $400mln in H1-25; profits hike 109%
Saudi German Hospital's revenues surpass $400mln in H1-25; profits hike 109%

Zawya

timean hour ago

  • Zawya

Saudi German Hospital's revenues surpass $400mln in H1-25; profits hike 109%

Riyadh – The net profit of Middle East Healthcare Company (Saudi German Hospital) hiked by 109.39% year-on-year (YoY) to SAR 223.80 million in the first half (H1) of 2025. The generated earnings were compared with SAR 106.88 million, according to the interim financial results. Revenues jumped by 8.77% to SAR 1.52 billion as of 30 June 2025 from SAR 1.40 billion in H1-24, while the earnings per share (EPS) increased to SAR 2.43 from SAR 1.16. Results for Q2-25 In the second quarter (Q2) of 2025, Saudi German Hospital recorded net profits valued at SAR 63.67 million, up 1.25% YoY from SAR 62.88 million. The group's revenues grew by 11.01% to SAR 791.13 million in April-June 2025 from SAR 712.66 million in Q2-24. Quarterly, the Q2-25 profits shrank by 60.23% from SAR 160.13 million in January-March 2025, while the revenues climbed by 7.82% from SAR 733.74 million. All Rights Reserved - Mubasher Info © 2005 - 2025 Provided by SyndiGate Media Inc. (

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store